The DOI matches its Crossref record.
Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily
Abstract
Background: On chronic intake of omeprazole, most healthy volunteers and patients still have nocturnal acid breakthrough (NAB), defined as night‐time periods with gastric pH < 4.0 lasting for longer than 1 h. Gastro‐oesophageal reflux during NAB may be particularly injurious to the oesophageal mucosa, contributing to the chronic lesions complicating the condition. Aim: To compare the effect of three different dosing regimens of omeprazole 40 mg daily with regard to suppressing nocturnal gastric acidity and avoiding NAB. Methods: Eighteen healthy volunteers were given three different regimens of omeprazole for 7 days each in randomized order: 40 mg before breakfast (qAM), 40 mg before dinner (qPM) and 20 mg before breakfast and dinner (b.d.). On day 7, 24‐h intragastric and intra‐oesophageal pH‐metry was performed. Tracings were analysed for the period from 22.00 h until 06.00 h with regard to the percentage of time at which gastric pH was below 4.0, 3.0 and 2.0, and also the occurrence and duration of NAB. Results: Nocturnal acid breakthrough was significantly more common on qAM than on qPM and b.d. (P < 0.05) dosing. The percentage of time gastric pH was less than 4.0 overnight was significantly lower on qPM (median 31.3) and b.d. (median 20.5) than on qAM (median 66.3) dosing (P = 0.01 and P < 0.02, respectively). A pH threshold of 3 and 4 showed the same differences, as did median 24‐h gastric pH. Daytime acidity was not significantly different. Conclusions: In healthy volunteers, dinner time or split dosing of omeprazole 40 mg daily is significantly more effective than dosing before breakfast in preventing NAB and controlling gastric acidity. These regimens should be preferred in patients in whom suppression of nocturnal gastric acidity is desirable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease
DeVault, K. R., & Castell, D. O. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41217.x · Cited by 1,130
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease
Katz, P. O., Dunbar, K. B., Schnoll-Sussman, F. H., Greer, K. B., Yadlapati, R., & Spechler, S. J. (2022) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001538 · Cited by 1,038
Control of Gastric Acid Secretion in Health and Disease
Schubert, M. L., & Peura, D. A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.021 · Cited by 481
Galmiche, J.-P., Hatlebakk, J., Attwood, S., Ell, C., Fiocca, R., Eklund, S., Långström, G., Lind, T., Lundell, L., & LOTUS Trial Collaborators, F. T. (2011) · JAMA · doi:10.1001/jama.2011.626 · Cited by 448
Management of heartburn not responding to proton pump inhibitors
Fass, R., & Sifrim, D. (2009) · Gut · doi:10.1136/gut.2007.145581 · Cited by 320
Metadata
- Authors
- Hatlebakk, Katz, Kuo, & Castell
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1998-12
- Volume
- 12
- Issue
- 12
- Pages
- 1235-1240
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2026353547
- Cited by
- 181
- References
- 0
- FWCI
- 8.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily. https://app.cochat.ai/papers/10.1046/j.1365-2036.1998.00426.x
- The paper
- Hatlebakk, Katz, Kuo, & Castell. (1998). Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.1998.00426.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.